ICPT logo

ICPT Current Liabilities

ICPT Annual Current Liabilities

$230.08 M
+$61.92 M+36.82%

31 December 2022

ICPT Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ICPT Quarterly Current Liabilities

$90.84 M
-$96.18 M-51.43%

30 September 2023

ICPT Quarterly Current Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ICPT Current Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+36.8%-59.0%
3 y3 years+42.0%-44.3%
5 y5 years+121.2%+2.8%

ICPT Current Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall timeat high-68.4%

Intercept Pharmaceuticals Current Liabilities History

DateAnnualQuarterly
Sept 2023
-
$90.84 M(-51.4%)
June 2023
-
$187.02 M(-9.7%)
Mar 2023
-
$207.12 M(-10.0%)
Dec 2022
$230.08 M(+36.8%)
$230.08 M(+3.8%)
Sept 2022
-
$221.58 M(+46.3%)
June 2022
-
$151.43 M(+0.3%)
Mar 2022
-
$151.04 M(-10.2%)
Dec 2021
$168.16 M(-6.1%)
$168.16 M(+16.9%)
Sept 2021
-
$143.85 M(-1.0%)
June 2021
-
$145.28 M(-0.7%)
Mar 2021
-
$146.23 M(-18.3%)
Dec 2020
$179.08 M(+10.5%)
$179.08 M(+9.8%)
Sept 2020
-
$163.12 M(-0.3%)
June 2020
-
$163.54 M(+9.0%)
Mar 2020
-
$149.97 M(-7.4%)
Dec 2019
$162.00 M(+41.9%)
$162.00 M(+15.7%)
Sept 2019
-
$139.97 M(+11.8%)
June 2019
-
$125.23 M(+15.6%)
Mar 2019
-
$108.34 M(-5.1%)
Dec 2018
$114.20 M(+9.8%)
$114.20 M(+29.2%)
Sept 2018
-
$88.42 M(-0.3%)
June 2018
-
$88.70 M(+11.7%)
Mar 2018
-
$79.45 M(-23.6%)
DateAnnualQuarterly
Dec 2017
$104.03 M(+32.5%)
$104.03 M(+18.8%)
Sept 2017
-
$87.59 M(+0.0%)
June 2017
-
$87.57 M(+20.5%)
Mar 2017
-
$72.68 M(-7.4%)
Dec 2016
$78.51 M(+65.7%)
$78.51 M(+44.0%)
Sept 2016
-
$54.53 M(-46.6%)
June 2016
-
$102.16 M(+2.9%)
Mar 2016
-
$99.25 M(+109.5%)
Dec 2015
$47.37 M(+210.8%)
$47.37 M(+47.2%)
Sept 2015
-
$32.18 M(+35.3%)
June 2015
-
$23.79 M(+31.0%)
Mar 2015
-
$18.15 M(+19.1%)
Dec 2014
$15.24 M(+71.6%)
$15.24 M(-7.6%)
Sept 2014
-
$16.50 M(+38.4%)
June 2014
-
$11.92 M(-95.8%)
Mar 2014
-
$287.12 M(+3132.9%)
Dec 2013
$8.88 M(-31.5%)
$8.88 M(+18.2%)
Sept 2013
-
$7.51 M(+4.8%)
June 2013
-
$7.16 M(-25.6%)
Mar 2013
-
$9.63 M(-25.7%)
Dec 2012
$12.96 M(+221.5%)
$12.96 M(+114.4%)
Sept 2012
-
$6.05 M(+7.9%)
June 2012
-
$5.60 M(+39.0%)
Dec 2011
$4.03 M
$4.03 M

FAQ

  • What is Intercept Pharmaceuticals annual total current liabilities?
  • What is the all time high annual current liabilities for Intercept Pharmaceuticals?
  • What is Intercept Pharmaceuticals annual current liabilities year-on-year change?
  • What is Intercept Pharmaceuticals quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Intercept Pharmaceuticals?
  • What is Intercept Pharmaceuticals quarterly current liabilities year-on-year change?

What is Intercept Pharmaceuticals annual total current liabilities?

The current annual current liabilities of ICPT is $230.08 M

What is the all time high annual current liabilities for Intercept Pharmaceuticals?

Intercept Pharmaceuticals all-time high annual total current liabilities is $230.08 M

What is Intercept Pharmaceuticals annual current liabilities year-on-year change?

Over the past year, ICPT annual total current liabilities has changed by +$61.92 M (+36.82%)

What is Intercept Pharmaceuticals quarterly total current liabilities?

The current quarterly current liabilities of ICPT is $90.84 M

What is the all time high quarterly current liabilities for Intercept Pharmaceuticals?

Intercept Pharmaceuticals all-time high quarterly total current liabilities is $287.12 M

What is Intercept Pharmaceuticals quarterly current liabilities year-on-year change?

Over the past year, ICPT quarterly total current liabilities has changed by -$130.74 M (-59.00%)